Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic effects differ in combination treatment

Bryant Furlow

    The Lancet. Oncology
    |August 30, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Trump Administration sparks furore and resignations over fruit-flavoured vape authorisations.

    The Lancet. Respiratory medicine·2026
    Same author

    Findings suggest under-reporting of patient data in US SEER.

    The Lancet. Oncology·2026
    Same author

    US Senate Bill aims to boost cancer trial enrolment and equity.

    The Lancet. Oncology·2026
    Same author

    Local coalitions track pollution in neglected US communities.

    The Lancet. Respiratory medicine·2026
    Same author

    Landmark verdicts against social media companies in the USA.

    The Lancet. Child & adolescent health·2026
    Same author

    Senators demand explanation for US Preventive Services Task Force halt.

    The Lancet. Oncology·2026
    Same journal

    Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

    The Lancet. Oncology·2026
    Same journal

    Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial.

    The Lancet. Oncology·2026
    Same journal

    Co-medications and gut microbiome in NSCLC immunotherapy.

    The Lancet. Oncology·2026
    Same journal

    Carcinogenicity of butyl benzyl phthalate, dibutyl phthalate, and diisononyl phthalate.

    The Lancet. Oncology·2026
    Same journal

    New report sheds light on cancer disparities in the USA.

    The Lancet. Oncology·2026
    Same journal

    Review highlights gaps in South Africa's cancer care.

    The Lancet. Oncology·2026
    See all related articles